News Extra Drugs companies are defrauding healthcare systems, conference hears BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7472.940-e (Published 21 October 2004) Cite this as: BMJ 2004;329:940 Article Related content Metrics Responses Peer review Related articles News German prosecutors probe again into bribes by drug companies Published: 03 June 2004; BMJ 328 doi:10.1136/bmj.328.7452.1333-a See more When your patient is a survivor of torture BMJ November 09, 2016, 355 i5019; DOI: https://doi.org/10.1136/bmj.i5019 Popular measure in California ballot targets drug prices BMJ October 28, 2016, 355 i5830; DOI: https://doi.org/10.1136/bmj.i5830 European drug agency launches website giving open access to trial data BMJ October 21, 2016, 355 i5700; DOI: https://doi.org/10.1136/bmj.i5700 Industry sponsorship hits the headlines BMJ October 19, 2016, 355 i5585; DOI: https://doi.org/10.1136/bmj.i5585 Beyond open data: realising the health benefits of sharing data BMJ October 10, 2016, 355 i5295; DOI: https://doi.org/10.1136/bmj.i5295
